Clinical Trials in Cleveland

Showing 4181-4200 of 19,775 trials

Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors

NCT02956291

The purpose of the research study is to test new methods that could improve diagnosis and assessment of brain tumors. One of these methods is a new MR (magnetic resonance) imaging technique called magnetic resonance fingerprinting (MRF), which allows for rapidly scanning the patient and provides quantitative information on tumor tissue. The investigators will compare the data gathered from MR Fingerprinting with other imaging tests, clinical information, treatment details and biopsy results to evaluate the accuracy of this new technique.

Brain Tumor

Case Comprehensive Cancer Center172 participantsStarted Feb 2017

Cleveland, Ohio, United States

RECRUITINGPhase 2< 1 mile

MB-105 in Patients With CD5 Positive T-cell Lymphoma

NCT06534060

This is a single arm, two-stage, Phase 2, open-label, multicenter study of MB-105 in patients with CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL). This study will apply a Simon two-stage optimal design.

Lymphoma, T-Cell

March Biosciences Inc46 participantsStarted Feb 2025

San Diego, California, United States • Denver, Colorado, United States • Tampa, Florida, United States +9 more locations

Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Find Trials by Condition in Cleveland

Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Comparing Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis

VItamin C in Thermal injuRY: The VICToRY Trial

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Hyperbaric Oxygen Brain Injury Treatment Trial

CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer

Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis

Improving Outcomes Assessment in Chronic GVHD

Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain